Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Dysplasia 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Melanoma 1Head and Neck Neoplasms 1HIV Infections 1Carcinoma, Renal Cell 1Carcinoma, Adenoid Cystic 1AIDS-related Kaposi sarcoma 1AIDS-Related Opportunistic Infections 1

Interventions

Paclitaxel 2nirogacestat 1halofuginone 1etoposide phosphate 1Thalidomide 1Sunitinib 1Semaxinib 1Saquinavir 1Ritonavir 1Peripheral Blood Stem Cell Transplantation 1Nelfinavir 1Interleukin-12 Subunit p35 1Indinavir 1Imatinib Mesylate 1Ifosfamide 1Filgrastim 1Etoposide 1Cidofovir 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × AIDS-related Kaposi sarcoma × Nelfinavir × Clear all
NCT00003008 2023-06-15

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Eastern Cooperative Oncology Group

Phase 2 Completed
33 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡